Loading…
Concord Medical Services Holdings Limited is projected to decline to $4.77 by 2027, a -2% move from its current price of $4.87. CCM is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $4.68 | $4.87 | $5.07 | +0.07% |
| May 30 | $4.61 | $4.88 | $5.16 | +0.14% |
| May 31 | $4.56 | $4.88 | $5.23 | +0.22% |
| Jun 1 | $4.51 | $4.88 | $5.29 | +0.29% |
| Jun 2 | $4.47 | $4.89 | $5.34 | +0.36% |
| Jun 3 | $4.44 | $4.89 | $5.39 | +0.43% |
| Jun 4 | $4.40 | $4.89 | $5.44 | +0.50% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.40 | $4.89 | $5.44 | +0.50% |
| Week 2 | $4.24 | $4.92 | $5.71 | +1.01% |
| Week 3 | $4.12 | $4.94 | $5.93 | +1.52% |
| Week 4 | $4.02 | $4.97 | $6.14 | +2.03% |
| Week 5 | $3.95 | $4.99 | $6.32 | +2.55% |
| Week 6 | $3.88 | $5.02 | $6.50 | +3.07% |
| Week 7 | $3.82 | $5.04 | $6.67 | +3.59% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Concord Medical Services Holdings Limited operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China, through its subsidiaries. It runs in two segments, Network and Hospital, delivering a range of cancer care and diagnostic services. The company’s offerings include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services, such as positron emission tomography-computed tomography and magnetic resonance imaging scanners.
It provides clinical support services such as developing treatment protocols for doctors, organizing joint diagnosis within its network, and supporting doctor recruitment and compensation decisions. It also offers radiotherapy and diagnostic equipment leasing, management services, premium cancer and proton treatment services to hospitals, teleconsultation and medical information technology services, and sells medical equipment. Additionally, the company operates specialty cancer hospitals offering radiation, imaging, test laboratory, inpatient, and nursing services.
Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
Concord Medical Services Holdings Limited (CCM) is a healthcare company focused on radiotherapy and diagnostic imaging in China. The current price is $4.91 with a market cap of $21.32M and a market rank of 4922.
The price outlook, based on the disclosed forecast, shows an upward trajectory in average prices over time—from $4.91 in 2026 to $30.30 on average by 2050—alongside bullish sentiment from 2029 onward. The forecast also highlights a wide potential price range and substantial long‑term upside, with the max price reaching $67.64 in 2050.
Shorter‑term dynamics show a neutral stance near term, while the longer horizon shifts to bullish as the outlook progresses. Note that some years trade with flat or negative ROI before the uptrend takes hold later in the forecast window.
A major floor 40.9% below — a decisive break under it would weaken the trend.
The nearest floor, 21.8% below — buyers have tended to step in here.
The nearest ceiling, 17.9% above — a clean break opens room to run.
A major ceiling 38.3% above — clearing it would confirm fresh momentum.
Key CCM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CCM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.83 | Buy | $4.89 | Sell |
| MA 10 | $4.99 | Sell | $4.92 | Sell |
| MA 20 | $4.90 | Sell | $4.81 | Buy |
| MA 50 | $4.25 | Buy | $4.46 | Buy |
| MA 100 | $4.14 | Buy | $4.36 | Buy |
| MA 200 | $4.62 | Buy | $4.60 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.58 | Neutral |
| Stoch RSI (14) | 7.01 | Buy |
| CCI (20) | -6.35 | Neutral |
| Williams %R (14) | -87.88 | Info |
| MACD (12,26,9) | -0.07 | Sell |
| ROC (12) | -15.16 | Sell |
| Bollinger %B (20,2) | 0.48 | Neutral |
| Stochastic %K (14) | 12.12 | Buy |
| TRIX (15) | 0.94 | Buy |
| Awesome (5,34) | 0.34 | Buy |
| Ultimate (7,14,28) | 37.23 | Neutral |
| Momentum (10) | -0.63 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 4.81 | Buy |
| ADX (14) | 20.95 | Buy |
| ATR (14) | 0.14 | Info |
The 30‑day technical picture is NEUTRAL with an RSI(14) of 60. The 50‑day simple moving average is $4.21 and the 200‑day simple moving average is $4.62. Support is at $3.81 and resistance at $5.74, framing a 30‑day range of $3.71–$6.49.
The asset exhibits high volatility, with annualized volatility listed at 80%, underscoring the potential for notable price moves within the month. The neutral sentiment and the current price positioning near the moving averages suggest limited directional bias in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.43 | $4.87 | $6.80 | 0% | Neutral | |
| $3.61 | $4.77 | $6.76 | -2% | Neutral | |
| $3.98 | $5.48 | $8.15 | +13% | Neutral | |
| $4.82 | $6.87 | $10.61 | +41% | Bullish | |
| $5.13 | $7.55 | $12.05 | +55% | Bullish | |
| $5.87 | $8.90 | $14.60 | +83% | Bullish | |
| $5.86 | $9.13 | $15.36 | +88% | Bullish | |
| $5.19 | $8.30 | $14.28 | +70% | Bullish | |
| $5.60 | $9.19 | $16.14 | +89% | Bullish | |
| $5.88 | $9.89 | $17.70 | +103% | Bullish | |
| $7.72 | $14.56 | $28.19 | +199% | Bullish | |
| $14.30 | $31.79 | $68.89 | +553% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.43 | $4.87 | $5.73 | +0.00% |
| June 2026 | $4.11 | $4.87 | $5.95 | +0.04% |
| July 2026 | $4.33 | $5.20 | $6.48 | +6.74% |
| August 2026 | $4.42 | $5.36 | $6.78 | +3.16% |
| September 2026 | $4.26 | $5.20 | $6.65 | -3.02% |
| October 2026 | $4.22 | $5.20 | $6.72 | -0.06% |
| November 2026 | $4.30 | $5.34 | $6.97 | +2.66% |
| December 2026 | $4.14 | $5.17 | $6.80 | -3.24% |
Click any year to see its month-by-month CCM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CCM could reach as high as $6.80, with a base case around $4.87 and support toward $3.43 — roughly 0% from $4.87. Price action looks broadly range-bound.
Expect CCM to range from $3.61 to $6.76 through 2027. The $4.77 average target implies a -2% move from current prices. That is -2% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The CCM price prediction for 2028 points to an average of $5.48 (low $3.98, high $8.15) — a potential gain of +13% on today's $4.87. Price action looks broadly range-bound.
In 2029, CCM is projected to trade between $4.82 and $10.61, averaging $6.87 — a potential gain of +41% from today's $4.87. That is up +25% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Concord Medical Services Holdings Limited's 2030 outlook centres on $7.55, within a $5.13 to $12.05 range. That is up +10% on the projected 2029 average. That marks a +55% change versus current levels. Momentum favours further upside here.
By 2031, CCM could reach as high as $14.60, with a base case around $8.90 and support toward $5.87 — roughly +83% from $4.87. Buyers look set to stay in control over this stretch.
Expect CCM to range from $5.86 to $15.36 through 2032. The $9.13 average target implies a +88% move from current prices. That is up +3% on the projected 2031 average. Momentum favours further upside here.
The CCM price prediction for 2033 points to an average of $8.30 (low $5.19, high $14.28) — a potential gain of +70% on today's $4.87. Buyers look set to stay in control over this stretch.
In 2034, CCM is projected to trade between $5.60 and $16.14, averaging $9.19 — a potential gain of +89% from today's $4.87. That is up +11% on the projected 2033 average. Momentum favours further upside here.
Concord Medical Services Holdings Limited's 2035 outlook centres on $9.89, within a $5.88 to $17.70 range. That is up +8% on the projected 2034 average. That marks a +103% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, CCM could reach as high as $28.19, with a base case around $14.56 and support toward $7.72 — roughly +199% from $4.87. Momentum favours further upside here.
Expect CCM to range from $14.30 to $68.89 through 2050. The $31.79 average target implies a +553% move from current prices. That is up +118% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CCM today (≈ 205.338809 CCM) could be worth
$6,527.01
+$5,527.01 (+553%) by 2050 · US Dollar
Based on the average projected CCM price of $31.79 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CCMwould be worth at today's price.
$1,000 invested in CCM on May 27, 2025 (≈ 141.843968 CCM) would be worth
$690.78
-$309.22 (-30.9%) today · 0.69× · US Dollar
Based on a CCM entry price of $7.05 vs. today's $4.87.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.75 | $1,025.26 | +2.5% |
| 1 month ago | $3.85 | $1,264.94 | +26.5% |
| 3 months ago | $3.5 | $1,391.43 | +39.1% |
| 6 months ago | $3.87 | $1,258.4 | +25.8% |
| 1 year ago | $7.05 | $690.78 | -30.9% |
| All time (5.0y) ago | $33 | $147.58 | -85.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CCM forecast.
Our base-case forecast reaches $9.70 around 2035.
Implied market cap at $9.70: $27.31M
The year‑by‑year forecast shows a clear long‑run upside with rising averages and strong bullish sentiment from 2029 onward. In 2026, the avg is $4.91 with a 0% ROI and NEUTRAL sentiment; the min is $3.43 and the max is $6.82. By 2027, the avg is $4.76 with a -3.1% ROI and NEUTRAL sentiment, followed by 2028 at an avg of $5.42 with a 10.4% ROI and NEUTRAL sentiment.
The uptrend accelerates through 2029–2035, with 2029 avg $6.72 and 36.8% ROI, 2030 avg $7.47 and 52.1% ROI, 2031 avg $8.84 and 80% ROI, 2032 avg $8.94 and 82% ROI, 2033 avg $8.06 and 64.2% ROI, 2034 avg $8.91 and 81.5% ROI, and 2035 avg $9.48 and 93.1% ROI, all with BULLISH sentiment.
Longer‑term horizons show continued growth: 2040 avg $14.09 with a 186.9% ROI and BULLISH sentiment, and 2050 avg $30.30 with a 517% ROI and BULLISH sentiment. These figures imply substantial upside over the multi‑year horizon, tempered by earlier years with more modest gains and occasional dips. Risks include the inherent uncertainty of forecasts and potential variability in market conditions and execution.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $7.47 with a min of $4.98 and a max of $12.13, and a 52.1% ROI. The sentiment is BULLISH.
The multi‑year outlook turns increasingly bullish from 2029 onward, with the avg price rising to $30.30 by 2050 and a 517% ROI at that horizon. Note that earlier years include a negative or flat ROI (e.g., 2027: -3.1%). Forecasts are estimates and not guarantees.
Yes. The max forecast by 2032 is $15.34 and by 2034 it is $15.99, with higher upside continuing into 2040 ($27.98 max) and 2050 ($67.64 max). The 2030–2035 period also shows values approaching or exceeding $15 in the max path.
Current price is $4.91 and market capitalization is $21.32M.
The 30‑day range is $3.71 to $6.49.
Concord Medical Services Holdings Limited Community Discussion
0Share your Concord Medical Services Holdings Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.